From: CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas
Series | Institution | Study period | Treatment Modality | No. of Patients/Lesions | Mean Marginal dose (Gy) | Mean Follow up (months) | Tumor control at last FU (%) |
---|---|---|---|---|---|---|---|
Coffey 1993[15] | Mayo Clinic | 1990-1992 | Gamma Knife | 5/11 | 15.5 | 14.8 | 81.8 |
Galanis 1998[18] | Mayo Clinic | 1976-1996 | Gamma Knife | 10/20 | 12-18 | 6-36 | 100* |
Payne 2000[10] | U of Virginia | 1991-1999 | Gamma Knife | 10/12 | 14 | 24.8 | 75 |
Sheehan 2002[3] | U of Pittsburgh | 1987-2001 | Gamma Knife | 14/15 | 15 | 31.3 | 80 |
Chang 2003[6] | Stanford | 1992-2002 | LINAC, CyberKnife | 8/8 | 20.5 | 44 | 75 |
Ecker 2003[8] | Mayo Clinic | 1980-2000 | Gamma Knife | 15/45 | 16 | 45.6 | 93^ |
Kano 2008[20] | U of Pittsburgh | 1989-2006 | Gamma Knife | 20/29 | 15 | 37.9 | 72.4 |
Sun 2009[11] | Beijing Neu. Ins. | 1994-2006 | Gamma Knife | 22/58 | 13.5 | 26 | 89.7 |
Iwai 2009[19] | Osaka City Hosp | 1994-2003 | Gamma Knife | 8/13 | 15.1 | 61 | 100 |
Olson 2010[9] | U of Virginia | 1989-2008 | Gamma Knife | 21/28 | 17 | 69 | 46.4 |
Veeravagu 2010 | Stanford | 2002-2009 | CyberKnife | 14/22 | 21.2 | 37 | 81.8 |